Logo image of BYL.CA

BAYLIN TECHNOLOGIES INC (BYL.CA) Stock Fundamental Analysis

TSX:BYL - Toronto Stock Exchange - CA0728191051 - Common Stock - Currency: CAD

0.31  +0.01 (+3.33%)

Fundamental Rating

1

BYL gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 15 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of BYL have multiple concerns. BYL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BYL had negative earnings in the past year.
BYL had a negative operating cash flow in the past year.
BYL had negative earnings in each of the past 5 years.
In the past 5 years BYL reported 4 times negative operating cash flow.
BYL.CA Yearly Net Income VS EBIT VS OCF VS FCFBYL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

The Return On Assets of BYL (-35.02%) is worse than 66.67% of its industry peers.
Industry RankSector Rank
ROA -35.02%
ROE N/A
ROIC N/A
ROA(3y)-39.45%
ROA(5y)-28.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BYL.CA Yearly ROA, ROE, ROICBYL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10K 20K 30K

1.3 Margins

BYL has a worse Gross Margin (40.42%) than 60.00% of its industry peers.
BYL's Gross Margin has been stable in the last couple of years.
BYL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.55%
GM growth 5Y0.83%
BYL.CA Yearly Profit, Operating, Gross MarginsBYL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

More info and screens

0

2. Health

2.1 Basic Checks

BYL does not have a ROIC to compare to the WACC, probably because it is not profitable.
BYL has more shares outstanding than it did 1 year ago.
BYL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BYL has an improved debt to assets ratio.
BYL.CA Yearly Shares OutstandingBYL.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
BYL.CA Yearly Total Debt VS Total AssetsBYL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -3.04, we must say that BYL is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.04, BYL is doing worse than 80.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.04
ROIC/WACCN/A
WACC8.8%
BYL.CA Yearly LT Debt VS Equity VS FCFBYL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.86 indicates that BYL may have some problems paying its short term obligations.
BYL has a worse Current ratio (0.86) than 73.33% of its industry peers.
A Quick Ratio of 0.55 indicates that BYL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.55, BYL is doing worse than 73.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.55
BYL.CA Yearly Current Assets VS Current LiabilitesBYL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 33.33% over the past year.
Looking at the last year, BYL shows a very strong growth in Revenue. The Revenue has grown by 30.98%.
Measured over the past years, BYL shows a very negative growth in Revenue. The Revenue has been decreasing by -11.72% on average per year.
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)30.98%
Revenue growth 3Y-15.18%
Revenue growth 5Y-11.72%
Sales Q2Q%-11.97%

3.2 Future

Based on estimates for the next years, BYL will show a very strong growth in Earnings Per Share. The EPS will grow by 37.54% on average per year.
BYL is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.34% yearly.
EPS Next Y71.14%
EPS Next 2Y37.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.23%
Revenue Next 2Y-4.34%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BYL.CA Yearly Revenue VS EstimatesBYL.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BYL.CA Yearly EPS VS EstimatesBYL.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BYL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BYL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BYL.CA Price Earnings VS Forward Price EarningsBYL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BYL.CA Per share dataBYL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

BYL's earnings are expected to grow with 37.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.54%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BYL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BAYLIN TECHNOLOGIES INC

TSX:BYL (2/21/2025, 7:00:00 PM)

0.31

+0.01 (+3.33%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)03-06 2025-03-06
Inst Owners0.61%
Inst Owner ChangeN/A
Ins Owners1.87%
Ins Owner ChangeN/A
Market Cap46.94M
Analysts47.5
Price Target0.51 (64.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.51%
Min EPS beat(2)-98.02%
Max EPS beat(2)67%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.72%
Min Revenue beat(2)-4.19%
Max Revenue beat(2)9.63%
Revenue beat(4)2
Avg Revenue beat(4)39.02%
Min Revenue beat(4)-26.46%
Max Revenue beat(4)177.08%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)66.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-150%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.29%
Revenue NQ rev (1m)17.75%
Revenue NQ rev (3m)-29.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.35
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.9
BVpS-0.04
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.02%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.42%
FCFM N/A
ROA(3y)-39.45%
ROA(5y)-28.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.55%
GM growth 5Y0.83%
F-Score4
Asset Turnover2.32
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 14.14%
Cap/Sales 0.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.55
Altman-Z -3.04
F-Score4
WACC8.8%
ROIC/WACCN/A
Cap/Depr(3y)13.85%
Cap/Depr(5y)37.3%
Cap/Sales(3y)1.29%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y71.14%
EPS Next 2Y37.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.98%
Revenue growth 3Y-15.18%
Revenue growth 5Y-11.72%
Sales Q2Q%-11.97%
Revenue Next Year-13.23%
Revenue Next 2Y-4.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year144.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y85.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y83.19%
OCF growth 3YN/A
OCF growth 5YN/A